Suppr超能文献

蜂毒针刺联合非甾体抗炎药治疗非特异性慢性颈痛的效果:一项随机、评估者盲法的试点临床试验。

Effect of Combined Bee Venom Acupuncture and NSAID Treatment for Non-Specific Chronic Neck Pain: A Randomized, Assessor-Blinded, Pilot Clinical Trial.

作者信息

Lee Boram, Seo Byung-Kwan, Kwon O-Jin, Jo Dae-Jean, Lee Jun-Hwan, Lee Sanghun

机构信息

Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.

Department of Acupuncture & Moxibustion, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.

出版信息

Toxins (Basel). 2021 Jun 23;13(7):436. doi: 10.3390/toxins13070436.

Abstract

This study aimed to investigate the feasibility of a combined treatment of bee venom acupuncture (BVA) and non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of non-specific chronic neck pain (NCNP). Patients with NCNP for ≥3 months were randomly allocated to a BVA, NSAIDs, or combined group (1:1:1), receiving 6 sessions of BVA, loxoprofen (180 mg daily), or a combination, respectively, for 3 weeks. Recruitment, adherence, and completion rates were calculated to assess feasibility. Bothersomeness, pain, disability, quality of life, depressive status, treatment credibility, and adverse events were assessed. In total, 60 participants were enrolled, and 54 completed the trial. Recruitment, adherence, and completion rates were 100%, 95%, and 90%, respectively. Bothersomeness, pain, disability, and depressive symptoms significantly improved in all groups after treatment ( < 0.05). The combined group showed continuous improvement during the follow-up period ( < 0.05). Quality of life was significantly improved ( < 0.05), and treatment credibility was maintained in the BVA and combined groups. No serious adverse events were reported. Combined treatment of BVA and NSAIDs are feasible for the treatment of NCNP, showing high persistence of the effect, credibility, and safety. Additional trials with longer follow-up are needed to confirm this effect.

摘要

本研究旨在探讨蜂毒针刺(BVA)与非甾体抗炎药(NSAIDs)联合治疗非特异性慢性颈部疼痛(NCNP)的可行性。将患有NCNP且病程≥3个月的患者随机分为BVA组、NSAIDs组或联合治疗组(1:1:1),分别接受6次BVA治疗、洛索洛芬(每日180毫克)治疗或联合治疗,为期3周。计算招募率、依从率和完成率以评估可行性。评估了不适感、疼痛、功能障碍、生活质量、抑郁状态、治疗可信度和不良事件。总共招募了60名参与者,54名完成了试验。招募率、依从率和完成率分别为100%、95%和90%。治疗后所有组的不适感、疼痛、功能障碍和抑郁症状均显著改善(<0.05)。联合治疗组在随访期间持续改善(<0.05)。生活质量显著提高(<0.05),BVA组和联合治疗组的治疗可信度得以维持。未报告严重不良事件。BVA与NSAIDs联合治疗NCNP是可行的,显示出疗效的高持续性、可信度和安全性。需要进行更长随访期的额外试验来证实这种效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c83/8309931/68bbbf8845a7/toxins-13-00436-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验